Lyrica — Class II drug recall D-0648-2016
Terminated recall by Pfizer Inc., reported 2016-02-10, distributed nationwide. FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potent
| Recall number | D-0648-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pfizer Inc., New York, NY, United States |
| Recall initiated | 2016-01-11 |
| Classified | 2016-02-01 |
| Reported by FDA | 2016-02-10 |
| Terminated | 2017-04-24 |
| Distributed | Nationwide (US) |
| Quantity | 30,672 bottles |
| NDC | 00071-1012, 00071-1012-68, 00071-1013, 00071-1013-41, 00071-1013-68, 00071-1014, 00071-1014-41, 00071-1014-68, 00071-1015, 00071-1015-41, 00071-1015-68, 00071-1016, 00071-1016-41, 00071-1016-68, 00071-1017, 00071-1017-68, 00071-1018, 00071-1018-68, 00071-1019, 00071-1019-68, 00071-1020, 00071-1020-01 |
| Lot numbers | M07861 |
| Expiration dates | 2018-05 |
Product
Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68
Reason for recall
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0648-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.